Attached files
| file | filename |
|---|---|
| 10-Q - Emergent BioSolutions Inc. | form10-q063016.htm |
| EX-10.3 - Emergent BioSolutions Inc. | ex10_3.htm |
| EX-10.2 - Emergent BioSolutions Inc. | ex10_2.htm |
| EX-3 - Emergent BioSolutions Inc. | ex3.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_1.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_1.htm |
EXHIBIT 12
|
Ratio of Earnings to Fixed Charges
|
|||||||||||||||||||||||
|
Year to Date
|
|||||||||||||||||||||||
|
|
June 30,
|
Year Ended December 31,
|
|||||||||||||||||||||
|
(in thousands)
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
|||||||||||||||||
|
|
|||||||||||||||||||||||
|
Pretax income (loss) from continuing operations (1)
|
$
|
(7,553)
|
|
$
|
89,769
|
$
|
53,062
|
$
|
44,243
|
$
|
37,446
|
$
|
38,849
|
||||||||||
|
Fixed charges
|
|||||||||||||||||||||||
|
Interest expense
|
3,860
|
7,834
|
7,480
|
1,973
|
2,177
|
1,719
|
|||||||||||||||||
|
Debt issuance cost
|
763
|
1,564
|
3,290
|
319
|
67
|
135
|
|||||||||||||||||
|
Total fixed charges (2)
|
4,623
|
9,398
|
10,770
|
2,292
|
2,244
|
1,854
|
|||||||||||||||||
|
Noncontrolling interest in pretax income (3)
|
-
|
-
|
-
|
876
|
5,381
|
6,906
|
|||||||||||||||||
|
Capitalized interest (4)
|
1,590
|
2,875
|
2,530
|
1,973
|
2,177
|
1,713
|
|||||||||||||||||
|
Earnings ((1) + (2) -(3) -(4))
|
(4,520)
|
|
96,292
|
61,302
|
43,686
|
32,132
|
32,084
|
||||||||||||||||
|
Fixed charges
|
4,623
|
9,398
|
10,770
|
2,292
|
2,244
|
1,854
|
|||||||||||||||||
|
Ratio of earnings to fixed charges
|
-
|
10.2
|
5.7
|
19.1
|
14.3
|
17.3
|
|||||||||||||||||
| Coverage deficiency | (7,553) | - | - | - | - | - | |||||||||||||||||